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Abstract
Background: Notions of equity are fundamental to, and drive much of the current thinking about
global health. Health inequity, however, is usually measured using health inequality as a proxy –
implicitly conflating equity and equality. Unfortunately measures of global health inequality do not
take account of the health inequity associated with the additional, and unfair, encumbrances that
poor health status confers on economically deprived populations.
Method: Using global health data from the World Health Organization's 14 mortality sub-regions,
a measure of global health inequality (based on a decomposition of the Pietra Ratio) is contrasted
with a new measure of global health inequity. The inequity measure weights the inequality data by
regional economic capacity (GNP per capita).
Results: The least healthy global sub-region is shown to be around four times worse off under a
health inequity analysis than would be revealed under a straight health inequality analysis. In
contrast the healthiest sub-region is shown to be about four times better off. The inequity of poor
health experienced by poorer regions around the world is significantly worse than a simple analysis
of health inequality reveals.
Conclusion: By measuring the inequity and not simply the inequality, the magnitude of the
disparity can be factored into future economic and health policy decision making.
Introduction
Inequity fuels the fire of moral outrage. It is justifiably and
acutely observable in the area of global health. Global
health researchers describe it, theorise about it, and look
for solutions to it [1-4]. In all these endeavors however,
there is a discomfort between knowing that inequity
exists, "knowing" that it is a significant problem, and
being able to say just how big a problem it is. At least a
part of the difficulty arises from the unclear relationship
between global health inequality and global health ineq-
uity.
Health inequality refers simply to the uneven distribution
of health in or between populations. Furthermore, some
health inequalities are unavoidable [5]. Never can the sit-
uation arise in which an entire population has the same
(i.e., equal) health status [6]. Nonetheless, health inequal-
ities should be of particular interest when those inequali-
ties are attributable to determinants that fall within the
capacity of people and societies to moderate. When these
kinds of disparities occur, the issue becomes one of health
inequities – not simply unevenness but unfairness in the
distribution of health. Health inequities may be thought
of as the presence of systematic disparities in health (or its
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social determinants) between more and less advantaged
social groups [[7], p.256, [8]].
Poverty is one such social determinant of health, possibly
the major social determinant, which is readily (if reluc-
tantly) amenable to human intervention. It is strongly
associated with health outcomes globally, and differences
in population health that are patterned by economic
capacity are frequently highlighted as examples of health
inequity [9,10].
It is a relatively straightforward matter to measure the ine-
quality in the global distribution of health. Measures of
health inequality include population attributable risk,
rate ratios, rate differences, and the concentration index
[11-14]. But just how unfair is a health inequality?
Consider the ratio of health outcomes for the highest and
lowest socioeconomic n-tile as a measure of health ine-
quality. This produces such observations as a 5.3 times
greater chance of under-five mortality among the poorest
quintile of Peruvians as for the richest quintile [[15],
p.11]. Similar statistics may be observed between the
health outcomes of the rich and the poor all over the
globe [16]. Indeed, a quick perusal of any recent World
Health Report will show a continuing and strong relation-
ship between national wealth and national health [17-
19].
There are difficulties, however, with any health equity
analysis that is based on a statistic of health inequality
[7,11,12]. Measures such as the concentration index, the
population attributable risk, or rate ratios, each implies a
one-to-one correspondence between the magnitude of the
inequality and the magnitude of the inequity. Although
each statistic may represent a sound empirical measure of
health inequality, it does not necessarily capture the nor-
mative aspects of the distributive unfairness of that ine-
quality [16]. In the absence of equity specific measures,
even among those acutely aware of the difference between
measuring an inequity and measuring an inequality
[20,21], the distinction is often lost.
Economically determined health inequalities are not sim-
ply unfair because societies have the capacity to redress
them. They are additionally unfair because the burden
that is experienced by a society in virtue of the popula-
tion's health is itself mediated by the population's wealth.
Wealthy regions have a greater capacity to support poor
health than poor regions, and this means that the impact
of poor health on both the individual sufferer and the
society is significantly less. Wealthy regions tend to have
invested in (and have the ongoing capacity to invest in)
better physical infrastructure, healthcare services, and
social services, all of which mitigate the impact of mortal-
ity and morbidity [22,23]. This means that any unfairness
associated with the uneven distribution of health is not
limited simply to the distribution of health itself.
It might reasonably be argued, therefore, that in an analy-
sis of health equity, the variation in population health
should be weighted by the wealth of the populations
under examination. This is grounded in the idea that, in a
fair world, those with the least economic capacity to over-
come the encumbrances of poor health should be those
who are most protected from it. Richer regions are in a
position to bear a greater health burden than poor
regions, because the richer regions have a greater eco-
nomic capacity to overcome the additional encumbrances
imposed by that poor health. Although health cannot, in
reality, be redistributed between populations, a counter
factual analysis based on this notion provides an insight
into the actual magnitude of the inequity. A similar
approach is taken by Gravelle (1998) in his "artefactual
argument" for the redistribution of individual income
[24].
Using global burden of disease data from the World
Health Organization (WHO), the magnitude of health
inequity in the regional distribution of health was exam-
ined by contrasting a new measure of health inequity (a
wealth-weighted measure of health inequality) against a
regular measure of health inequality.
Methods
The equity of the distribution of health status was exam-
ined using data from the 14 global mortality sub-regions
of the WHO [18,25]. The six WHO regions were Africa
(AFRO), the Americas (AMRO), Eastern Mediterranean
(EMRO), Europe (EURO), South East Asia (SEARO), and
the Western Pacific (WPRO). Each region was further sub-
divided into between two and four sub-regions according
to the adult and child mortality profile of country clusters:
very low child and low adult mortality (A), low child and
low adult mortality (B), low child and high adult mortal-
ity (C), high child and high adult mortality (D), and high
child and very high adult mortality (E). The division of
regions into sub-regions resulted in 14 mortality sub-
regions, a complete list of which (including the constitu-
ent countries) is provided in Appendix I [see Additional
file 1].
The measure of population health that was used was the
disability adjusted life year (DALY) [26]. This was used in
preference to other measures of health, because it was
conceptually clearer to think about redistributing DALY's
between populations than, say, the mortality rate. The
DALY is a measure of years of life lost attributable to mor-
bidity and mortality within a population and has been
used by the WHO [18] and some national governmentsInternational Journal for Equity in Health 2007, 6:16 http://www.equityhealthj.com/content/6/1/16
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[27] as a measure of the burden of disease. The measure of
population wealth that was used was the gross national
product (GNP) [28]. GNP is the broadest measure of
national income and comprises gross domestic product
plus net receipts of primary income from nonresident
sources.
Data
The data on the total number of DALYs and the size of the
population of each mortality sub-region for 2000 was
obtained from "GBD 2000 Version 1 Estimates" available
from the WHO website. The DALY makes adjustments for
age and sex at the time that death or disability occurred
and a discount rate was also applied to the years of life
lost.
The GNP for each of the mortality sub-regions was derived
from the World Bank "World Development Indicators –
1999" CD-ROM, following adjustment for the purchasing
power of an "international dollar" in each sub-region
[28]. The 2000 GNP was estimated by multiplying each
sub-region's population for 2000 by the relevant 1999
GNP per capita. The use of a purchasing power parity
(PPP) measure overcame, to some degree, the undervalu-
ing of consumption in economies with relatively low
prices and the overvaluing of consumption in countries
with high prices.
Where GNP figures were unavailable for a country within
a mortality sub-region, the median GNP per capita for the
remaining countries was used to estimate the missing
country's GNP. A sensitivity analysis revealed that there
was little difference in the overall results whether missing
country data were imputed on the basis of a sub-region's
median, mean, maximum or minimum GNP per capita.
Analysis
The analysis is based on the decomposition of an index of
inequality known as the Pietra Ratio [29], or Robin Hood
Index [30]. The index was so named because in the con-
text of wealth inequality it approximates the share of
wealth that has to be transferred from those with greater
than the mean-level resources and given to those with less
than mean-level resources in order to achieve equality. In
effect it is the share of the wealth that has to be robbed
from the rich and given to the poor. In the context of this
article, health inequality represents the share of the bur-
den of disease as measured by the DALY, that needs to be
transferred from the regions with the worst per capita
health and transferred to the regions with the best per cap-
ita health in order to achieve health equality.
Although the Pietra Ratio is a single number reflecting the
amount of wealth (or in this case, health) that needs to be
transferred to achieve equality; rather than a single global
index one can provide a decomposition of the ratio, indi-
cating the extent to which each member of the population
(in this case WHO sub-regions) needs to transfer wealth
(or health) to ensure equality.
It is easiest to describe the approach to the analysis with
reference to real data, and this is done as the article
progresses.
Results & discussion
Globally, in 2000 there were 0.247 DALYs per capita. That
is, a quarter of a DALY had been lost for every living per-
son. Regionally, the distribution was uneven with AFROE
(0.635 DALYs per capita) and AFROD (0.502 DALYs per
capita) showing the worst population health outcomes,
and WPROA (0.107 DALYs per capita) and EUROA
(0.129 DALYs per capita) showing the best population
health outcomes.
The magnitude of the is demonstrable in a number of
ways, with the Lorenz curve being one of the better known
illustrations (Figure 1). The curve is fitted directly to the
data points and hence the lack of deviation. Having
ordered the WHO sub-regions according to their DALYs
per capita burden, the Lorenz curve shows the proportion
of global DALYs that are accounted for, by any given pro-
portion of the world's population. Under conditions of
equality (i.e., DALYs per capita are equal for each mortal-
ity sub-region), one would observe 10% of the DALYs
accounted for by 10% of the world's population, 20% of
the DALYs accounted for by 20% of the world's popula-
tion, and so on. This line of equality appears as the
straight (dotted) line. The degree to which the actual data
(the solid line) deviate from the line of equality illustrates
The Lorenz curve of the global distribution of health  (DALYs) by WHO mortality sub-region Figure 1
The Lorenz curve of the global distribution of health 
(DALYs) by WHO mortality sub-region.
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the degree to which poor heath is unequally distributed
across the mortality sub-regions.
The inequality in the geographical distribution of the bur-
den of disease is clear. The African region (the AFROE and
AFDROD sub-regions combined), for example, accounts
for about 10% of the world's population. It also accounts
for about 24% of the global DALYs; i.e., 2.4 times the bur-
den of disease that would be expected under conditions of
equality. The inclusion of one of the Eastern Mediterra-
nean mortality sub-regions (EMROD) shows that around
16% of the world's population accounts for around 32%
of the global DALYs, still twice as large as would be
expected under conditions of equality. Progressively, the
inclusion of more regions sees the magnitude in the ine-
quality decline. This pattern of inequality in distribution
is entirely in keeping with expectation given that WPROA,
the sub-region with the best health outcomes, includes
countries like Australia, New Zealand, and Japan, while
AFROE, the sub-region with the worst health outcomes,
includes countries like South Africa, Burundi, Mozam-
bique, and Rwanda.
If the magnitude of the inequality is assumed to corre-
spond to the magnitude of the inequity, then one way to
consider the problem of health equity is to ask the follow-
ing. If one were to redistribute the DALYs in such a way
that each sub-region bore the same per capita burden of
disease (i.e., health were distributed equally), how would
that redistribution manifest itself? This invites a form of
counterfactual analysis similar to one used by Allotey and
Reidpath to examine the global distribution of refugees
[31].
Given that the global average DALYs per capita in 2000
were 0.247, by multiplying each sub-regions population
by the global average the "expected" number of DALYs in
each sub-region under conditions of equality can be cal-
culated. The WHO sub-region AFROE, for example, had a
population of approximately 330 million people in 2000.
If health were distributed equally across sub-regions, one
would expect AFROE to have experienced 81.5 million
DALYs. The actual DALYs for the sub-region were approx-
imately 209.6 million DALYs. In the monetary language
of the Pietra Ratio, AFROE would have to reduc its burden
to 40% of its actual level to achieve health equality. The
ratio of the expected and the actual (or observed) DALYs
per capita in each sub-region indicates the magnitude of
the increase or decrease in the burden of disease that
would be required in that sub-region for equality in the
distribution of health to be achieved.
Figure 2 shows the plot of the log ratio of expected and
actual DALYs per capita for each of the 14 mortality sub-
regions. A loess regression line is plotted against the
points. A horizontal, reference line that assumes pre-exist-
ing equality is also plotted at 0 on the y-axis. Deviations
are minimized because the data points (mortality sub-
regions) are pre-ordered from low to high (left to right).
The percentage decrease in the burden of disease required
by those regions lying below the line of equality – or the
percentage increase in the burden of disease required by
those regions lying above the line of equality – can be esti-
mated from the graph by calculating the 10x value of a
region's log-ratio on the right-hand axis. For equality in
the distribution of global health to be achieved the two
African sub-regions would need to reduce their burden of
disease to around 40% (AFROE) and 50% (AFROD) of
their respective levels – that is, 10-0.41 and 10-0.31. EMROD
would need to reduce its burden to around 80% of its
level, as would SEAROD. EUROC and AMROD experi-
enced very close to the burden of disease expected under
conditions of global equality. All the other regions would
be expected to increase their burden of disease. WPROB
EMROB would need to increase the burden of disease by
50%. AMROA would need to increase the burden by 70%,
EUROA by 90%, and WPROA by 230%!
Stark as the results are, however, they represent an analysis
of health inequality, with a presumption that the magni-
tude of the inequality corresponds to the magnitude of
inequity. As argued earlier, however, the unfairness (i.e.,
inequity) inherent in the distribution of health is not sim-
ply one of inequality. Even were health as measured by
the DALY distributed equally across the sub-regions, the
true burden would remain unequally distributed. It is also
the wealth of sub-regions that allows them to mitigate the
impact of morbidity and mortality on individuals, house-
The log ratio of expected to actual per capita health (DALYs)  illustrating the inequality of health distribution by WHO  mortality sub-region Figure 2
The log ratio of expected to actual per capita health (DALYs) 
illustrating the inequality of health distribution by WHO 
mortality sub-region.
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holds, and society. Ceteris paribus, for any given per capita
level of DALY, the negative impact of poor health will be
less in a wealthier sub-region than in a poorer sub-region
[22,23]. An analysis of health equity, rather than simply
health inequality, would need to take this into account. In
order to ascertain the magnitude of a health inequity, the
question needs to be rephrased to realize the advantage
that wealth offers a mortality sub-region in coping with
the burden of disease. Specifically, given two regions with
the same size population, one with a per capita GNP twice
that of the other, one may "expect" under conditions of
equity that the wealthier region would bear a greater bur-
den of disease – and to simplify the illustration we will
assume that it would bear a greater burden in direct pro-
portion to its greater wealth – that is, twice the burden.
Thus, instead of assuming that it would be equitable for
each sub-region to achieve identical DALYs per capita
(i.e., .247 per capita), it is assumed that each region
should achieve a level of DALYs per capita in proportion
to its per capita wealth. The sub-region WPROA has a per
capita wealth of $23,685 and the sub-region AFROE has a
per capita wealth $1802. Under this form of equity,
WPROA would be expected to experience a per capita
DALYs level of 13.14 times that of AFROE. Table 1 shows
the DALYs per capita and the GNP per capita for each of
the mortality sub-regions.
The counterfactual world of equitably distributed DALYs
is created by redistributing all 1472 million DALYs in such
a way that each sub-region's "expected" DALYs per capita
stand in the same ratio to each other as their GNP per cap-
ita. Following the same general approach as before, Figure
3 shows the plot of the log ratio of expected and actual
DALYs per capita for each of the 14 mortality sub-regions
given a GNP adjusted distribution of the burden of dis-
ease. The scale on the y-axis is the same as in Figure 2, and
again, a loess regression line is plotted, as is a reference
line assuming pre-existing equality. There is slightly
greater observable deviation than in Figure 3 – an artifact
of the data.
The most striking feature of the figure is that the gradient
of the loess line is generally much steeper than the equiv-
alent line in Figure 2, indicating that the inequity embod-
ied in the distribution of health is far greater than one
would imagine if overcoming inequity was seen as the
logical end-point of health policy. Under an equitable
model of health redistribution the African region (both
AFROE and AFROD) should carry about 10% of the bur-
den of disease that it currently carries. EMROD and
SEAROD should carry only 20% of the burden that they
currently carry, and EUROC and AMROD would carry
only 70% of the burden that they currently carry. On the
other hand EUROA would have to support 600% of the
burden that it currently supports, AMROA would have to
support almost 800% and WPROA would have to support
almost 900%!
The least healthy WHO mortality sub-region, AFROE, is
around four times worse off under a health inequity anal-
ysis than would be revealed under a straight health ine-
quality analysis. The healthiest sub-region, WPROA, is
about four times better off. This suggests that an analysis
based on the inequality of health substantially under-
counts the magnitude of the health inequity.
Table 1: The distribution of health (DALYs), wealth (GNP) and population across the 14 WHO mortality sub-regions.
Region Sub-Region Population 
(1,000,000)
GNP (USD$ PPP) 
($1,000,000)
DALYs 
(1,000,000)
GNP per Capita DALYs per Capita
AFRO E 330 594660 210 1802 0.635
AFRO D 286 412309 144 1442 0.502
EMRO D 348 672567 111 1933 0.319
SEARO D 1219 1939586 365 1591 0.299
EURO C 246 954966 60 3882 0.244
AMRO D 70 262236 17 3746 0.240
SEARO B 289 1156093 60 4000 0.209
EURO B 215 1182823 40 5502 0.187
AMRO B 425 3082915 80 7254 0.187
WPRO B 1521 5158738 249 3392 0.164
EMRO B 137 825521 22 6026 0.164
AMRO A 318 9019217 46 28362 0.145
EURO A 410 8095845 53 19746 0.129
WPRO A 153 3623750 16 23685 0.107
Global 5967 36981225 1472 6198 0.247International Journal for Equity in Health 2007, 6:16 http://www.equityhealthj.com/content/6/1/16
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One might construct an argument on the basis of these
results indicating that the way to achieve an equitable dis-
tribution of health would be to increase the health burden
in those healthier populations. This is a completely logical
consequence of any measure (such as this one) which is
based around an underlying measure of inequality;
because inequality can always be reduced by decreasing
the advantage of those who are most advantaged. At the
time of the analysis there were 1472 million DALYs to be
redistributed. Increasing the health burden of the healthi-
est populations would by its very nature improve the
health equity of this measure, but it would be completely
undesirable to increase the global burden of disease. More
cancer for the USA, Canada, and Australia is not the strat-
egy of choice.
Measures of an inequity do not necessarily embody the
appropriate policy intervention, and it would be a mistake
to assume that they do or that they should. An alternative
and more palatable approach to reducing the magnitude
of the inequity would be to improve the health and
wealth of the poorest and most burdened populations of
the world.
Before concluding, there are some possible limitations
associated with the analysis. The two most significant lim-
itations relate to the regional nature of the analysis, and
the approach used to weight the data by regional wealth.
Regions, or more particularly WHO mortality sub-
regions, are not homogenous. Countries within regions
can differ markedly from one to another. For instance,
Cuba and the United States, two radically different
national entities, are included in the same sub-region in
virtue of their mortality profile, but obviously without
regard to their wealth. Sub-region aggregation, however, is
a feature of current DALYs data, which are not available at
the country level. Although country level data would be
preferable, the association between per capita wealth and
per capita health at the sub-region level is broadly similar
to what is known about the association at the national
and sub-national level. The results of the analysis, there-
fore, are not an artifact of the regional aggregation of data.
There is also a question about the appropriateness of the
wealth weighting function as a compensatory device for
translating a health inequality measure into a health ineq-
uity measure. The equity analysis assumes that every addi-
tional dollar per capita has a constant effect on the
encumbrance of poor health. The extent to which this
assumption is reasonable requires further investigation
and alternative weighting functions could be applied. It is
unlikely, however, that more dollars per capita would ever
be a bad thing in the context of the equity weighting.
Under these circumstances the thrust of the present find-
ings would remain, although the ultimate shape of the
wealth weighting function becomes a question for further
investigation.
Conclusion
An analysis of health equity requires more than the iden-
tification of socially determined health inequality, or the
measurement of the magnitude of the inequality. The
encumbrances of poor health, that is, the direct burden of
the disease and the broader social and economic costs are
affected by factors such as the quality and availability of
supportive physical infrastructure, healthcare services,
and social services. Wealthy regions enjoy better physical
infrastructure, healthcare services, and social services, all
of which mitigate the impact of poor health [22,23].
Because these mitigators are functions of societies' wealth,
in an analysis of health equity, wealth needs to be factored
in to the measurement process.
The inequity of poor health experienced by poorer regions
around the world is significantly worse than a simple
analysis of health inequality reveals. By measuring the
inequity and not simply the inequality, the magnitude of
the disparity can be factored into future economic and
health policy decision making.
Additional material
Additional file 1
WHO subregions. A list of the 14 WHO mortality regions, sub-regions, 
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The log ratio of expected to actual per capita health (DALYs)  weighted by per capita wealth (GNP) illustrating the inequity  of health distribution by WHO mortality sub-region Figure 3
The log ratio of expected to actual per capita health (DALYs) 
weighted by per capita wealth (GNP) illustrating the inequity 
of health distribution by WHO mortality sub-region.
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